Charming Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Charming Medical Limited (MCTA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period EndingMar 2025Dec 2024Mar 2023
Operating Activities
Net Income1.201.20-0.31
Depreciation & Amortization0.260.260.21
Deferred Income Tax0.130.130.00
Change in Working Capital-1.16-1.162.50
Change in Accounts Receivable-0.04-0.04-0.15
Change in Inventory0.000.00-0.06
Change in Accounts Payable-0.10-0.200.18
Change in Other Working Capital-0.01-0.910.06
Other Operating Activities-0.01-0.010.06
Net Cash from Operating Activities0.430.432.43
Investing Activities
Capital Expenditures-0.29-0.29-0.61
Purchases of Investments-1.94-1.940.00
Net Cash from Investing Activities-2.23-2.23-0.61
Financing Activities
Debt Repayment-0.160.05-0.18
Other Financing Activities0.470.47-1.25
Net Cash from Financing Activities0.520.52-1.43
Summary
Effect of Forex Changes on Cash0.000.000.01
Net Change in Cash-1.28-1.290.40
Cash at Beginning of Period2.102.101.53
Cash at End of Period0.820.821.93
Free Cash Flow0.140.141.83
Supplemental Disclosures
Interest Paid0.020.030.02